Hagens Berman Reminds Investors in Pluralsight (PS) of Ongoing Investigation, Investors Who Suffered $50,000+ Losses May Contact the Firm
August 13, 2019 20:12 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Pluralsight, Inc. (NASDAQ: PS) of the Firm’s ongoing investigation of possible violations of the...
AC/Fluid Leak Detection Kit Reduce Costs and Down Time While Increasing Labor Effectiveness
August 09, 2016 13:46 ET
|
Tracer Products
WESTBURY, NY--(Marketwired - August 09, 2016) - Fleet management isn't easy. Problems just seem to increase with the size and number of vehicles that need to be maintained. Fixing all those problems...
Peregrine Licenses Novel Exosome-Based Cancer Detection and Monitoring Technology from UT Southwestern Medical Center
July 14, 2016 08:05 ET
|
Peregrine Pharmaceuticals Inc.
--New Technology Efficiently Builds on the Company’s Existing Phosphatidylserine (PS) Targeting Platform and Assay Development Capabilities-- --Stand Alone Program That Offers Significant...
Preclinical Data Presented at American Association for Cancer Research (AACR) Annual Meeting Demonstrate Enhanced Therapeutic Benefit of Combining a PS-Targeting Antibody With Anti-PD-1 Therapy in Models of Triple Negative Breast Cancer (TNBC)
April 20, 2016 08:05 ET
|
Peregrine Pharmaceuticals Inc.
- Statistically Significant Improvement in Overall Survival for Combination as Compared to Anti-PD-1 Therapy Alone in TNBC Models; Combination Also Protects Against Re-Challenge With TNBC Tumor...
Jomar Corporation Introduces "CR" Series of Injection Blow Molding Machines for Conventional Resins
May 01, 2012 18:12 ET
|
Jomar
PLEASANTVILLE, NJ--(Marketwire - May 1, 2012) - In response to less processing of engineering resins on injection blow molding machinery, Jomar Corporation has developed a new "CR" series...